scispace - formally typeset
A

Arthur Partikian

Researcher at University of Southern California

Publications -  14
Citations -  407

Arthur Partikian is an academic researcher from University of Southern California. The author has contributed to research in topics: Epilepsy & Medicine. The author has an hindex of 6, co-authored 11 publications receiving 370 citations. Previous affiliations of Arthur Partikian include University of California, San Francisco & City of Hope National Medical Center.

Papers
More filters
Journal ArticleDOI

Rapid Diffusion of Green Fluorescent Protein in the Mitochondrial Matrix

TL;DR: The rapid and unrestricted diffusion of solutes in the mitochondrial matrix suggests that metabolite channeling may not be required to overcome diffusive barriers, and it is proposed that the clustering of matrix enzymes in membrane-associated complexes might serve to establish a relatively uncrowded aqueous space in which solutes can freely diffuse.
Journal ArticleDOI

Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms.

TL;DR: While etiology and response to first medication predict better outcomes, the majority of patients with infantile spasms continue to have epilepsy with long-term motor and cognitive disabilities.
Journal ArticleDOI

SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.

Bobby G. Ng, +74 more
- 01 Jul 2019 - 
TL;DR: In this paper, a robust and reliable biochemical assay was developed to assess SLC35A2-dependent UDP-galactose transport activity in primary fibroblasts and showed that transport activity is directly correlated to the ratio of wild-type to mutant alleles in fibroblast from affected individuals.
Journal ArticleDOI

Major Adverse Events Associated With Treatment of Infantile Spasms

TL;DR: Despite early changes in weight and blood pressure, short courses of high-dose natural adrenocorticotropic hormone are generally well tolerated with no increased major adverse events when compared to antiepileptic drugs in the treatment of infantile spasms.
Journal ArticleDOI

Iatrogenic botulism in a child with spastic quadriparesis.

TL;DR: The case of a 10-year-old boy who developed systemic weakness following treatment of spasticity with botulinum toxin type B is described, and the patient developed iatrogenic botulism with ptosis, facial diplegia, neck flexor and extensor weakness.